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Enterococcus Faecalis Endocarditis: A Case Study
Torri Curtis, BSN, RN, OCN
Otterbein University, Westerville, Ohio
Introduction
Infectious endocarditis is an
uncommon disease of the heart
stemming from a bacterial or fungal
infection on the endocardial surface of
the heart or heart valve (Pierce, Calkins,
& Thornton, 2012). From review of the
literature, infective endocarditis is fairly
uncommon and may be difficult to
initially diagnose. Per Sabe, Shrestha,
and Menon, occurrence of infective
endocarditis (IE) is nearly 0.9-6.2 per
100,000 persons per year (2013).
Several preexisting conditions such as
aging, heart valve disease, implantable
cardiac devices, a history of heart
disease such as rheumatic fever, and
invasive procedures can put a patient at
higher risk for IE (Leone et al., 2012).
As the occurrence of IE appears to be
rare, it is important to emphasize that
the complications of this infection are
abundant even when treated acutely and
appropriately. Per Mantan, Sethi, and
Batra, the infection-related
complications of IE can include
myocardial abscess, meningitis,
osteomyelitis, renal abscess, renal
infarcts, glomerulonephritis, and
purulent pericarditis (2013, p. 368).
However, this list of complications is not
all inclusive. The risks of thrombolytic
events are increased with IE and one can
experience a stroke, pulmonary
embolism, and even blindness (Mantan
et al., 2013). Treatment for infectious
endocarditis must be expediential and
persistent. Long term intravenous
antibiotics are the treatment of choice
and surgery may be indicated especially
if a patient has a prosthetic valve
endocarditis (Sabe et al., 2013).
As infective endocarditis is an
uncommon disease, the
pathophysiologic impact on the body is
significant. Proper diagnosis,
management, and long term follow up
could be improved through a better
understanding of the disease process
and systemic effects on the body. As a
result, a case study involving a patient
diagnosed with Enterococcus faecalis
infective endocarditis was chosen for
review.

Presentation of Case
Signs and Symptoms
A 54 year old male with a prior
medical history of hypertension,
pyelonephritis, nephrolithiasis, and
acute prostatitis presented to the
emergency room in July of 2014 with
symptoms of rigors, chills, fever,

diplopia, and lower extremity edema
and weakness. Upon presentation,
temperature was 102.0 F, pulse rate
was 98, respirations were 24, blood
pressure was 100/58 and oxygen
saturation on room air was 90%.
Pain level was 7. Skin was
diaphoretic and warm to touch.
Pupils equal, round, and react to light.
Bilateral lower extremity edema
present with erythema. Positive
Homan’s sign. Lab results revealed
hemoglobin of 9.3. Blood cultures
positive for Enterococcus faecalis. CT
scan of abdomen negative. CT scan of
brain negative. Chest x-ray normal.
EKG was normal. Venous Doppler
study negative. Renal ultra sound
showed stable nephrolithiasis. Prior
to admission, patient had been
treated with IV antibiotics of
Ampicillin 2 grams IV every 4 hours
and Rocefin 1 gram every day for 2
weeks for treatment of positive blood
cultures of gram positive cocci.
Patient was admitted for fever of
unknown origin. IV antibiotics were
initiated. Consultations were
performed by the infectious disease
and cardiology teams. A
transthoracic echocardiogram was
performed which revealed mitral
valve vegetation, minimal mitral valve
regurgitation, and a normal ejection
fraction of 55-60%. With positive
blood cultures for Enterococcus
faecalis and mitral valve vegetation
by transthoraic echocardiogram, a
diagnosis of Enterococcus faecalis
endocarditis was made. IV antibiotics
of Ampicillin 2 grams every 4 hours
and Gentamycin 1 gram every 8
hours were initiated. After blood
pressure and fever stabilized and
negative blood cultures were
obtained, patient was discharged to
home on IV Ampicillin 2 grams every
4 hours and IV Gentamycin 1 gram
every 8 hours via PICC line for 4
weeks. After completion of antibiotic
therapy, patient had follow up with
infectious disease physician and
cardiologist. A repeat transthoracic
echocardiogram was completed
which showed anterior mitral valve
leaflet thickening with no
enlargement of the echo density seen
on prior exam and borderline
concentric left ventricular
hypertrophy with mass not
prolapsing into left atrium. Ejection

fraction was 55-60%. Patient will have
continued follow up exams with a
cardiologist and infectious disease
physician to monitor and screen for
any complications related to infective
endocarditis such as recurrent
infection, congestive heart failure,
valvular dysfunction, or organ
dysfunctions. Patient was also
instructed to report any fever greater
than 100.0 F immediately. Patient was
also instructed to have antibiotic
therapy prophylactically prior to dental
appointments or invasive procedures.
Underlying Pathophysiology
An infection caused by bacteria that
enters the bloodstream and settles in
the heart lining, valve, or blood vessel
is endocarditis. As bacteria is the most
common cause of IE, viruses, fungi, and
parasites can also cause IE (McCance,
Huether, Brashers, & Rote, 2014).
Blood cultures commonly isolated for
IE are Staphylococcus aureus, viridans
Streptococcus, and Enterococcus
faecalis (Pierce et al., 2012).
Enterococcus faecalis is the third most
common cause of infective endocarditis
and the mortality and morbidity is high
(Miro, Pericas, & Del Rio, 2014).
Although infective endocarditis refers
specifically to infection in the lining of
the heart, IE also affects the valves and
muscles of the heart ("American Heart
Association," 2014).
The pathophysiology of IE includes
three elements of endocardial damage,
blood-borne microorganism adherence
to the endocardial surface that is
damaged, and the formation of
infective endocardial vegetations
(McCance et al., 2014). Endocardial
damage can include trauma, heart
disease, prosthetic valves and valvular
heart disease (McCance et al., 2014). IE
also requires the presence of a
microorganism in the blood and the
attachment to the intracardiac surface
(Pierce et al., 2012). This can occur by
mode of trauma, dental procedures,
cardiac surgery, and central line
infections. The infective endocardial
vegetations infiltrate the thrombi in the
cardiac tissue and then accelerate
fibrin formation by activating the
clotting cascade as the bacterial
colonies are rooted in the fibrin clots;
making them inaccessible to host
defenses (McCance et al., 2014). After
the microorganism settles on the

cardiac surface, the infection can
disseminate to other tissues in the body
causing a systemic infection ("National
Institutes of Health," 2010).

Renal complications of IE occurs in
approximately 25% of the patients
and the most common diagnosis are
renal infarcts, renal abscesses,
glomerulonephritis and interstitial
nephritis (Mantan et al., 2013).

Implications for
Nursing Care

Figure 1: Infectious Endocarditis of
Mitral Valve (Cabell, Abrutyn, &
Karchmer, 2003, figure 1).
Significance of Pathophysiology
Infective endocarditis is
uncommon, but the effects from the
disease process can involve several
organ systems including cardiac,
neurological, musculoskeletal and
renal systems and can be fatal if not
treated in an expedited fashion.
Infection related complications of IE
can include embolism, heart valve
destruction and heart failure,
osteomyelitis, pericarditis,
glomerulonephritis, and blindness
(Mantan et al., 2013). Embolic risk
occurs in 22%-50% of patients with
IE and involve complication of
stroke and pulmonary embolism
(Anavekar et al., 2011). Emboli
from IE can often involve the lungs,
coronary arteries, spleen, GI system,
extremities, and central nervous
system (Chung, Chen, Tai, Huang, &
Chen, 2014). Embolic events related
to IE can cause devastating
neurologic damage and organ
failure (Sabe et al., 2013). Cardiac
complications are serious and
include formations of heart
murmurs, heart valve regurgitation,
and congestive heart failure
(Mocchegian & Nataloni, 2009).
Additional complications include
damage to the conduction system of
the heart leading to bundle branch
block, intra-cardiac fistulas, and
pericarditis (Sabe et al., 2013).
Heart valve replacement may need
to be a consideration if patient has
extensive damage to a heart valve.

The clinical manifestations and
multi-organ involvement of IE are
many. Diagnosis of IE is based on
clinical, microbiologic, and
echocardiographic findings (Chung et
al., 2014). Evaluation and work up
for diagnosis of IE should include
cardiac assessment for heart murmur
or heart failure which would include
a baseline electrocardiogram, an
echocardiogram, blood cultures prior
to initiation of antibiotic therapy,
evaluation for petechiae of mucous
membranes and extremities,
complete blood count, serum
electrolytes, and urinalysis for
hematuria, proteinuria, or pyuria
(Pierce et al., 2012). The principles of
therapy for IE is initial hemodynamic
stabilization, obtaining blood cultures
for microbial identification and
treatment (Sabe et al., 2013).
Echocardiography is also one
diagnostic modality in patients with
suspected IE. Evaluation of IE has
improved dramatically after the
introduction of echocardiography
which is the primary technique for
the detection of vegetations on the
heart wall and valves and IE related
complications (Cecchi et al., 2013).
Clinical judgment is crucial in the first
stages of care for a patient with IE.
Systematic evaluation and
assessment is essential and nurses
evaluating patients can be advocates
in the initiation of appropriate tests
and evaluations. Although
uncommon, knowing predictive
factors for IE is useful in identifying
patients with IE. These factors
include: being male, prior valvular
heart damage, fever, stroke, emboli,
splenomegaly, leukocytosis, and
thrombocytopenia (Chung et al.,
2014). The latest American Heart
Association guidelines recommend
penicillin or ampicillin plus
gentamicin for 4 to 6 weeks as the
combination of choice for
Enterococcus faecalis infective
endocarditis (Miro et al., 2014). It is
also imperative to have an infectious

disease consultation for the patient
in addition to a cardiology consult.
ID consultation has been associated
with improved outcomes including
improved survival (Yamamoto et al.,
2012). Follow up and patient
education is important. Intravenous
catheters should be removed
immediately following completion of
antibiotic therapy and transthoracic
echocardiography should be
performed to establish a new
baseline result for the patient
(Pierce et al., 2012). Patients should
also receive education regarding the
importance of regular follow up
visits to their specialists including
infectious disease and cardiology.
(Pierce et al., 2012). In addition,
patients need to know that they may
require antibiotic therapy prior to
invasive procedures. The American
Heart Association recommends
antibiotic prophylaxis prior to dental
procedure for patients with a history
of IE ("American Heart Association,"
2014).

Figure 2: Infectious Endocarditis of
Mitral Valve (American Heart
Association website, 2008).

Conclusions
Infective endocarditis occurs at a
low rate, but can be associated with
high morbidity and mortality, with
mortality occurring at a rate of 1540%, in light of antibiotic and
surgical advancements (Sabe et al.,
2013). Early diagnosis of IE is
crucial for successful clinical
outcomes and prevention of long
term complications. Treatment of IE
should be targeted toward the
causative microorganism, based on
the cardiac valve involved, and the
clinical status of the patient (Sabe et
al., 2013).

A multimodality approach in care
and treatment is essential and
should include a collaborative effort
between the infectious disease
specialist, primary care physician,
cardiologist, cardiothoracic
surgeons, and nursing team.
Through enhanced awareness of IE,
improved outcomes from this
disease can be realized.
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